Table 3.
Multivariable logistic regression for fracture among 18–64 year olds with cerebral palsy.
Women |
Men |
|||
---|---|---|---|---|
Model 1 OR (99.5% CI) |
Model 2 OR (99.5% CI) |
Model 1 OR (99.5% CI) |
Model 2 OR (99.5% CI) |
|
Sample size, n | 7657 | 7657 | 8831 | 8831 |
Race | ||||
White | Reference | Reference | Reference | Reference |
Black | 0.57 (0.37, 0.88) | 0.57 (0.37, 0.89) | 0.38 (0.22, 0.65) | 0.39 (0.23, 0.68) |
Hispanic | 1.09 (0.53, 2.23) | 1.10 (0.54, 2.26) | 0.87 (0.44, 1.74) | 0.85 (0.42, 1.70) |
Age (as continuous) | 1.03 (1.02, 1.05) | 1.03 (1.02, 1.04) | 1.02 (1.01, 1.03) | 1.02 (1.01, 1.03) |
Region | ||||
Northeast | Reference | Reference | Reference | Reference |
West | 1.03 (0.67, 1.58) | 1.08 (0.70, 1.67) | 1.06 (0.70, 1.61) | 1.07 (0.70, 1.62) |
Midwest | 1.35 (0.96, 1.91) | 1.39 (0.98, 1.96) | 0.94 (0.65, 1.35) | 0.93 (0.64, 1.34) |
South | 1.18 (0.83, 1.67) | 1.20 (0.84, 1.70) | 0.89 (0.62, 1.27) | 0.86 (0.60, 1.25) |
Intellectual disabilities | 1.21 (0.93, 1.56) | 1.24 (0.95, 1.61) | 1.18 (0.89, 1.56) | 1.23 (0.93, 1.64) |
Autism spectrum disorders | 1.70 (1.03, 2.82) | 1.64 (0.99, 2.74) | 1.21 (0.72, 2.04) | 1.13 (0.67, 1.92) |
Epilepsy | 1.40 (1.08, 1.80) | 1.40 (1.08, 1.82) | 1.25 (0.95, 1.64) | 1.25 (0.94, 1.65) |
Ischemic heart diseases | 1.42 (0.86, 2.36) | 0.99 (0.58, 1.68) | ||
Cerebrovascular diseases | 1.28 (0.83, 1.96) | 1.25 (0.80, 1.96) | ||
Hypertensive and other cardiovascular diseases | 1.14 (0.87, 1.50) | 1.07 (0.80, 1.44) | ||
Diabetes | 1.04 (0.74, 1.46) | 1.05 (0.73, 1.52) | ||
Mood affective disorders | 1.23 (0.93, 1.62) | 1.35 (1.00, 1.83) | ||
Anxiety disorders | 1.36 (1.03, 1.80) | 1.50 (1.11, 2.02) | ||
Substance abuse disorders | 1.63 (0.83, 3.21) | 2.55 (1.53, 4.25) | ||
Chronic obstructive pulmonary disease | 1.18 (0.76, 1.82) | 1.28 (0.82, 1.99) | ||
Chronic kidney disease | 1.06 (0.64, 1.75) | 1.02 (0.60, 1.76) | ||
Liver diseases | 0.87 (0.49, 1.55) | 0.97 (0.55, 1.70) | ||
Cancer | 1.65 (1.04, 2.62) | 0.49 (0.20, 1.19) |
OR, odds ratio; CI, confidence interval.